MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

Начало・Списък с акции・Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

86.59 -0.53

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

83.05

Максимум

86.67

Ключови измерители
By Trading Economics
Приходи	5.4M -48M
Продажби	6M 57M
Марж на печалбата	-82.974
Служители	414
EBITDA	5.1M -43M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+57.7% upside

Дивиденти
By Dow Jones
Следващи печалби	6.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-492M 5.9B
Предишно отваряне	87.12
Предишно затваряне	86.59

Настроения в новините

By Acuity

75%

25%

318 / 349 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

60 / 65.58 Подкрепа & съпротива

Rhythm Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.04.2026 г., 17:26 ч. UTC

Значими събития в новините

EIA Raises Oil-Price Forecasts as War in Middle East Continues

7.04.2026 г., 23:55 ч. UTC

Пазарно говорене

Genesis Energy Signals Higher Dividend Payout Ratios -- Market Talk

7.04.2026 г., 23:47 ч. UTC

Пазарно говорене

Значими събития в новините

Market Talk Roundup: Latest on U.S. Politics

7.04.2026 г., 23:47 ч. UTC

Пазарно говорене

Значими събития в новините

Precious Metals Rise, Boosted by Dollar Weakness, Lower Treasury Yields -- Market Talk

7.04.2026 г., 23:44 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Rallies as Trump Remarks Send Oil Prices Lower -- Market Talk

7.04.2026 г., 23:42 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

7.04.2026 г., 23:42 ч. UTC

Пазарно говорене

Nikkei Likely to Rise After Trump Agrees to Cease-Fire With Iran -- Market Talk

7.04.2026 г., 23:37 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Fall After Trump Agrees to Two-Week Cease-Fire With Iran -- Market Talk

7.04.2026 г., 23:15 ч. UTC

Пазарно говорене

Значими събития в новините

Markets Will Want Fast Evidence That Ships Are Moving -- Market Talk

7.04.2026 г., 23:04 ч. UTC

Значими събития в новините

Spot Gold Rises 2.5%, Spot Silver Climbs 4.9%

7.04.2026 г., 23:04 ч. UTC

Значими събития в новините

Precious Metals Rise After Trump Agrees to Ceasefire With Iran

7.04.2026 г., 23:03 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

7.04.2026 г., 23:03 ч. UTC

Пазарно говорене

Middle East Ceasefire Triggers Australian Dollar Rally -- Market Talk

7.04.2026 г., 23:01 ч. UTC

Значими събития в новините

Front-Month WTI Crude Oil Futures Falls 13.7% to $97.47 per Barrel

7.04.2026 г., 22:58 ч. UTC

Значими събития в новините

Front-Month Crude Oil Futures Slide After Trump Agrees to Cease-Fire With Iran

7.04.2026 г., 21:56 ч. UTC

Придобивния, сливания и поглъщания

Telefónica Sells All Shares in Pegaso PCS, Celular de Telefonía

7.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Значими събития в новините

Basic Materials Roundup: Market Talk

7.04.2026 г., 20:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

7.04.2026 г., 19:45 ч. UTC

Пазарно говорене

Treasury Yields Mixed as Investors Brace for Iran Deadline -- Market Talk

7.04.2026 г., 19:17 ч. UTC

Значими събития в новините

The Risks to the Gulf Region's Oil Are Immense. Are Markets Shrugging Them Off? -- Barrons.com

7.04.2026 г., 19:16 ч. UTC

Пазарно говорене

Cold Shot Helps U.S. Natural Gas Futures Settle Higher -- Market Talk

7.04.2026 г., 19:07 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

7.04.2026 г., 19:07 ч. UTC

Пазарно говорене

Oil Futures Mixed Ahead of Trump's Iran Deadline -- Market Talk

7.04.2026 г., 18:41 ч. UTC

Придобивния, сливания и поглъщания

Eldorado Gold: Total of 149.6M Common Shrs, Representing 75.31% of Votes Attached to All Outstanding Common Shrs, Were Voted >ELD.T

7.04.2026 г., 18:40 ч. UTC

Придобивния, сливания и поглъщания

Eldorado Gold Holders Voted to Approve Issuance of Common Shrs in Connection With Proposed Plan of Arrangement With Foran Mining >ELD.T

7.04.2026 г., 18:39 ч. UTC

Придобивния, сливания и поглъщания

Eldorado Gold Reports Voting Results From Special Meeting of Hldrs

7.04.2026 г., 18:24 ч. UTC

Значими събития в новините

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7.04.2026 г., 17:08 ч. UTC

Пазарно говорене

Latin America Less Exposed to Crude Supply Disruptions -- Market Talk

7.04.2026 г., 16:21 ч. UTC

Значими събития в новините

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7.04.2026 г., 16:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Rhythm Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

57.7% нагоре

12-месечна прогноза

Среден 137.14 USD 57.7%

Висок 158 USD

Нисък 105 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за Rhythm Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

14 ratings

Купи

Задържане

Продай

Според 14 анализатори, дали борсови рейтинги на Rhythm Pharmaceuticals Inc през последните 3 месеца.

Техническа оценка

By Trading Central

60 / 65.58Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Настроение

By Acuity

318 / 349 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.